Welcome, MedTech Professionals.
2025 W1 Edition of The MedTech AI Monitor
2025 is the year AI will be impossible to ignore. Companies will be folding in GenAI to every possible feature and use case. Agentic AI will be the #1 discussed and debated topic this year. My prediction? We won’t see truly useful Agent applications until the end of the year.
Autonomous systems that can reason, plan, and act with minimal human intervention, is still in its infancy. The potential is huge, but so are the technical and ethical challenges. Building agents that are reliable, scalable, and aligned with human intent is harder than many expect.
When we do get it right, the impact will be game-changing, especially in MedTech. Imagine an Agentic AI system that acts as a virtual clinical assistant. It could autonomously:
- Cross-reference thousands of clinical trials in minutes to suggest the most relevant ones for a patient’s condition.
- Manage medical device performance, running diagnostics and scheduling maintenance before failures occur.
- Generate detailed compliance reports, freeing up valuable time for medical professionals.
But we’re not quite there yet. Expect 2025 to be a year of experimentation and refinement in Agentic AI, with breakthroughs toward the end of the year.
How are you getting prepared to adopt it when it does?
-Greg Matson
tl;dr
Ransomware, vulnerabilities threaten healthcare security.
Robotics drove MedTech innovation in 2024.
Zero Trust and AI improve cybersecurity defenses.
1. IoT and Ransomware are Big Security Risks, Health Systems Feel Unprepared
Healthcare organizations are increasingly targeted by ransomware and IoT vulnerabilities, with nearly 400 U.S. healthcare entities affected in 2024, according to Veriti. AI-enhanced attacks exploit unpatched devices, while 50% of providers lack confidence in breach detection, and 42% lack strong data access policies. Risks are compounded by endpoint misconfigurations and outdated recovery processes. To combat threats, organizations are adopting Zero Trust, virtual patches, and AI-driven threat analysis, while emphasizing intelligence sharing and proactive measures to mitigate future attacks. [Link]
2. Robots, AI and PFA: The Top MedTech Q&As of 2024
With AI and robotics at the forefront, 2024 showcased the MedTech industry's focus on innovation, regulation, and expanding patient care capabilities. Discussions ranged from CMR Surgical’s challenge to Intuitive Surgical’s robotics dominance to Medtronic’s use of AI in heart disease diagnostics. Other notable Q&As covered AI oversight challenges, advancements in pulsed field ablation, and innovations in retinal imaging and orthopedic technology. Leaders from Abbott, Johnson & Johnson, and Canary Medical shared insights on new devices and market trends. [Link]
3. Korea Recruits For $1 Billion Bio Data Project
South Korea has launched its largest healthcare initiative, the National Integrated Bio Big Data Construction Project, aiming to collect clinical and genomic data from one million individuals over eight years. This $400 million effort will support precision medicine and digital healthcare research starting in 2026. Meanwhile, AIIMS Delhi is establishing an AI Health Innovations Hub in partnership with Wipro GE Healthcare, focusing on AI-driven solutions in cardiology, oncology, and neurology. In Thailand, NEC is advancing digital elderly care through a healthcare platform and IoT-enabled remote care, with plans to expand this model nationwide. [Link]
📌 AI Job Board
Director, AI Strategy and Partnerships - Medical Device, Phillips, $178,000/yr - $306,000/yr
Director – Medical/In Vitro Device Artificial Intelligence, Oriel
Managing Director, Tech & AI Solutions - AI Consulting Leader, Trinity Life Sciences, $270,000/yr - $300,000/yr
🗞️ In Other News
📄 Doc Control
Anthropic introduces Clio (Claude insights and observations), a system that uses AI assistants to analyze usage patterns across millions of its Claude 3,5 model interactions while preserving user privacy. [Paper Link]
The two main use cases for Clio? Understanding broad usage patterns and improving Anthropic's safety systems.
The views and opinions expressed in this email are for informational purposes only. They do not constitute legal advice. Readers are encouraged to consult with their own legal counsel regarding any specific legal questions or issues related to the topics discussed.
